Effect of Diet on Men and Women With Genetic Alterations Associated With Abnormal Blood Tests
Not Applicable
Completed
- Conditions
- Dyslipidemia
- Registration Number
- NCT00108212
- Lead Sponsor
- US Department of Veterans Affairs
- Brief Summary
The purpose of this study is to evaluate different diets and the effects of blood measures or inflammation and endothelial function in association with genetics tending to abnormal blood test levels.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Polymorphism in Apo C3 promoter and normal controls.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link genetic variants in TG-rich lipoproteins to diet-induced changes in inflammation markers in NCT00108212?
How do dietary interventions in NCT00108212 compare to statin therapy for managing dyslipidemia in genetically predisposed patients?
Which biomarkers correlate with improved endothelial function following low-fat or Mediterranean diets in the VA's NCT00108212 trial?
What adverse metabolic effects are observed in NCT00108212 participants with APOE4 or LPL gene alterations during dietary trials?
How do findings from NCT00108212 inform combination therapies of diet and PCSK9 inhibitors for familial hypercholesterolemia patients?
Trial Locations
- Locations (1)
VA Maryland Health Care System
🇺🇸Baltimore, Maryland, United States
VA Maryland Health Care System🇺🇸Baltimore, Maryland, United States